Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus
|ClinicalTrials.gov Identifier: NCT01535248|
Recruitment Status : Completed
First Posted : February 17, 2012
Last Update Posted : December 2, 2015
|Condition or disease||Intervention/treatment|
|Air Embolism as A Complication of Medical Care||Other: Transthoracic Echocardiography|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||17 participants|
|Official Title:||Echocardiographic Surveillance of Patients Undergoing Scheduled Endoscopic Retrograde Cholangiopancreatography for the Presence of Intracardiac Air Embolus|
|Study Start Date :||March 2012|
|Primary Completion Date :||November 2015|
|Study Completion Date :||November 2015|
All ERCP Patients
All patients that will be approached for this study will be undergoing ERCP as part of their medical care.
Other: Transthoracic Echocardiography
Patients undergoing ERCP will have surveillance with transthoracic echocardiography with exams occurring every 10 mins or more often if needed to evaluate for the presence of intra-cardiac air associated with ERCP insufflation.
Other Name: Monitoring
- Incidence of ERCP associated air embolism [ Time Frame: Participation will be for one day, during the time of the ERCP ]Patients who are scheduled for ERCP as part of their routine care will be assessed for the presence of air embolus, both clinically relevant (in the form of hemodynamic changes) and those situations where air is identified and does not appear to have a clinical effect. This is scheduled to occur over one day's time and only during the procedure are we planning on performing the echo for surveillance of air emboli.
- Risk Factors associated with ERCP air embolus [ Time Frame: Participation will be for one day, during the time of the ERCP ]If it is found that there is a significant number of individuals that are found to have ERCP associated air embolus it would be a secondary goal to attempt to identify patient factors that might confer additional risk of air embolus to the patient.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01535248
|United States, Nebraska|
|The Nebraska Medical Center|
|Omaha, Nebraska, United States, 68198|
|Principal Investigator:||Nicholas W Markin, MD||University of Nebraska|